Related Experiment Video
Updated: Mar 3, 2026

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
Published on: July 5, 2024
Evaluating Potential Effects of Chamomile (Matricaria chamomilla L.) in Polycystic Ovary Syndrome: A Systematic
Zahra Firoozi1, Roghayeh Molani-Gol1, Vahideh Ebrahimzadeh-Attari2
1Student Research Committee Tabriz University of Medical Sciences Tabriz Iran.
Abstract:
The present study aimed to systematically assess the effects of Chamomile consumption on some biochemical parameters and clinical symptoms in patients with polycystic ovary syndrome (PCOS). The search was performed across the databases PubMed, Web of Science, Scopus, and Google Scholar using relevant keywords, with no language or date restrictions, up to the 4th of December 2024. Given the limited number of studies, results from both human and animal research were considered. The risk of bias for included studies was evaluated. For clinical studies, meta-analyses were conducted using Stata, and a random-effects model was used to estimate effect sizes. Four animal and four human studies were qualified for this review. Almost all animal studies indicated that Chamomile improved clinical, hormonal, and oxidative stress parameters in PCOS. Furthermore, almost all human studies have shown that Chamomile supplementation improves the clinical features of PCOS. However, the pooled analysis of two eligible human studies showed that there was no statistically significant effect of Chamomile supplementation on serum lipid profile including LDL-C (ES = 1.73, 95% CI (-6.49, 9.94), p = 0.680), TG (ES = -7.23, 95% CI (-29.34, 14.89), p = 0.522), and HDL-C (ES = -0.07, 95% CI (-5.85, 5.70), p = 0.980). Moreover, the pooled analysis of three eligible human studies demonstrated no statistically significant effect of Chamomile on serum testosterone levels (ES = 5.05, 95% CI = (-1.38, 11.49), p = 0.124). Overall, animal studies have demonstrated the potential benefits of Chamomile consumption in the treatment of PCOS, possibly through anti-androgenic, anti-inflammatory, analgesic, and antioxidant effects. In contrast, human studies yielded heterogeneous findings, with improvements in clinical features but no significant impact on serum testosterone or lipid profile parameters. Therefore, further well-designed clinical trials are needed to make more definitive decisions.
Related Concept Videos
Oogenesis
Disorders of the Female Reproductive System
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Ovarian Cycle
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...

